Literature DB >> 33936441

Modeling Disease Progression Trajectories from Longitudinal Observational Data.

Bum Chul Kwon1, Peter Achenbach2, Jessica L Dunne3, William Hagopian4, Markus Lundgren5, Kenney Ng1, Riitta Veijola6, Brigitte I Frohnert7, Vibha Anand1.   

Abstract

Analyzing disease progression patterns can provide useful insights into the disease processes of many chronic conditions. These analyses may help inform recruitment for prevention trials or the development and personalization of treatments for those affected. We learn disease progression patterns using Hidden Markov Models (HMM) and distill them into distinct trajectories using visualization methods. We apply it to the domain of Type 1 Diabetes (T1D) using large longitudinal observational data from the T1DI study group. Our method discovers distinct disease progression trajectories that corroborate with recently published findings. In this paper, we describe the iterative process of developing the model. These methods may also be applied to other chronic conditions that evolve over time. ©2020 AMIA - All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33936441      PMCID: PMC8075441     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  17 in total

1.  Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci.

Authors:  S Nejentsev; M Sjöroos; T Soukka; M Knip; O Simell; T Lövgren; J Ilonen
Journal:  Diabet Med       Date:  1999-12       Impact factor: 4.359

2.  The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.

Authors:  Jeffrey P Krischer; Kristian F Lynch; Desmond A Schatz; Jorma Ilonen; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Olli G Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Ezio Bonifacio
Journal:  Diabetologia       Date:  2015-02-10       Impact factor: 10.122

3.  A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.

Authors:  David Endesfelder; Michael Hagen; Christiane Winkler; Florian Haupt; Stephanie Zillmer; Annette Knopff; Ezio Bonifacio; Anette-G Ziegler; Wolfgang Zu Castell; Peter Achenbach
Journal:  Diabetologia       Date:  2016-07-11       Impact factor: 10.122

4.  Disease Progression Modeling: Key Concepts and Recent Developments.

Authors:  Sarah F Cook; Robert R Bies
Journal:  Curr Pharmacol Rep       Date:  2016-08-15

5.  Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.

Authors:  Berglind Jonsdottir; Christer Larsson; Markus Lundgren; Anita Ramelius; Ida Jönsson; Helena Elding Larsson
Journal:  Autoimmunity       Date:  2018-08       Impact factor: 2.815

6.  Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

Authors:  M Rewers; T L Bugawan; J M Norris; A Blair; B Beaty; M Hoffman; R S McDuffie; R F Hamman; G Klingensmith; G S Eisenbarth; H A Erlich
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

7.  Disease progression modeling using Hidden Markov Models.

Authors:  Rafid Sukkar; Elyse Katz; Yanwei Zhang; David Raunig; Bradley T Wyman
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012

8.  Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).

Authors:  Andrea K Steck; Kendra Vehik; Ezio Bonifacio; Ake Lernmark; Anette-G Ziegler; William A Hagopian; JinXiong She; Olli Simell; Beena Akolkar; Jeffrey Krischer; Desmond Schatz; Marian J Rewers
Journal:  Diabetes Care       Date:  2015-02-09       Impact factor: 17.152

9.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Authors:  William A Hagopian; Henry Erlich; Ake Lernmark; Marian Rewers; Anette G Ziegler; Olli Simell; Beena Akolkar; Robert Vogt; Alan Blair; Jorma Ilonen; Jeffrey Krischer; JinXiong She
Journal:  Pediatr Diabetes       Date:  2011-05-12       Impact factor: 3.409

Review 10.  Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.

Authors:  Richard A Insel; Jessica L Dunne; Mark A Atkinson; Jane L Chiang; Dana Dabelea; Peter A Gottlieb; Carla J Greenbaum; Kevan C Herold; Jeffrey P Krischer; Åke Lernmark; Robert E Ratner; Marian J Rewers; Desmond A Schatz; Jay S Skyler; Jay M Sosenko; Anette-G Ziegler
Journal:  Diabetes Care       Date:  2015-10       Impact factor: 19.112

View more
  4 in total

1.  Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children.

Authors:  Kenney Ng; Vibha Anand; Harry Stavropoulos; Riitta Veijola; Jorma Toppari; Marlena Maziarz; Markus Lundgren; Kathy Waugh; Brigitte I Frohnert; Frank Martin; Olivia Lou; William Hagopian; Peter Achenbach
Journal:  Diabetologia       Date:  2022-10-05       Impact factor: 10.460

2.  Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.

Authors:  Kenney Ng; Harry Stavropoulos; Vibha Anand; Riitta Veijola; Jorma Toppari; Marlena Maziarz; Markus Lundgren; Kathy Waugh; Brigitte I Frohnert; Frank Martin; William Hagopian; Peter Achenbach
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 17.152

3.  Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories.

Authors:  Bum Chul Kwon; Vibha Anand; Peter Achenbach; Jessica L Dunne; William Hagopian; Jianying Hu; Eileen Koski; Åke Lernmark; Markus Lundgren; Kenney Ng; Jorma Toppari; Riitta Veijola; Brigitte I Frohnert
Journal:  Nat Commun       Date:  2022-03-21       Impact factor: 14.919

4.  Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S.

Authors:  Vibha Anand; Ying Li; Bin Liu; Mohamed Ghalwash; Eileen Koski; Kenney Ng; Jessica L Dunne; Josefine Jönsson; Christiane Winkler; Mikael Knip; Jorma Toppari; Jorma Ilonen; Michael B Killian; Brigitte I Frohnert; Markus Lundgren; Anette-Gabriele Ziegler; William Hagopian; Riitta Veijola; Marian Rewers
Journal:  Diabetes Care       Date:  2021-06-23       Impact factor: 17.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.